EVA SLOMIAK: Open Payments
NPI 1700519352 · SHELTON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$922 in 56 payments from 7 companies in 2025. Trend: 2023 $192 · 2024 $1,193 · 2025 $922
Food & beverage: $922
| Company | Payments | Amount |
|---|---|---|
| Indivior Inc. | 11 | $258 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 17 | $246 |
| Ardelyx, Inc. | 12 | $194 |
| Collegium Pharmaceutical, Inc. | 12 | $142 |
| Azurity Pharmaceuticals, Inc. | 2 | $39 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $19 |
Products named: SUBLOCADE, RELISTOR, IBSRELA, Belbuca, HORIZANT, JOURNAVX, TRELEGY ELLIPTA.
Industry payments across CT — which companies pay providers there.
